✦ LIBER ✦

S1836 Glucagon Like Peptide 1 (GLP-1) Attenuates Hepatic Steatosis in Nonalcoholic Steatohepatitis in Diabetic Mice

✍ Scribed by Nakade, Yukiomi; Kanamori, Hiroyuki; Tsunekawa, Akihisa; Ohashi, Tomohiko; Sato, Ken; Nakao, Haruhisa; Yoneda, Masashi

Book ID: 123177064
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 46 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63683-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucagon-Like Peptide-1 (GLP-1) Analogue

Glucagon-Like Peptide-1 (GLP-1) Analogue Inhibited Hepatic Inflammation in Nonalcoholic Steatohepatitis (NASH)

✍ Nakade, Yukiomi ;Yamamoto, Takaya ;Banno, Fumi ;Kanamori, Hiroyuki ;Ohashi, Tomo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Tu1813 Effect of Glucagon-Like Peptide-1

Tu1813 Effect of Glucagon-Like Peptide-1 (GLP-1) Analogue on Hepatic Cholesterol Metabolism in Nonalcoholic Steatohepatitis (NASH)

✍ Nakade, Yukiomi; Yamamoto, Takaya; Banno, Fumi; Kanamori, Hiroyuki; Ohashi, Tomo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Exendin-4, a glucagon-like protein-1 (GL

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

✍ Xiaokun Ding; Neeraj K. Saxena; Songbai Lin; Narita Gupta; Frank A. Anania 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Nonalcoholic fatty liver disease (NAFLD) represents a burgeoning problem in hepatology, and is associated with insulin resistance. Exendin-4 is a peptide agonist of the glucagon-like peptide (GLP) receptor that promotes insulin secretion. The aim of this study was to determine whether administration

Glucagon-like peptide-1(9-36)amide metab

Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice

✍ E. Tomas; J. A. Wood; V. Stanojevic; J. F. Habener 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

Targeting amyloid-beta by glucagon-like

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes

✍ Bak, Ann Mosegaard; Egefjord, Lærke; Gejl, Michael; Steffensen, Charlotte; Stech 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 448 KB

GLP-1-derived nonapeptide GLP-1(28–36)am

GLP-1-derived nonapeptide GLP-1(28–36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice

✍ Eva Tomas; Jenna A. Wood; Violeta Stanojevic; Joel F. Habener 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 692 KB